Instructions for Reglisam (ammonium glycyrrhizate)
ATX code:
R07AX (Respiratory drugs other)
Active ingredient Reglisam:
ammonium glycyrrhizinate (ammonium glycyrrhizate)
Ph.Eur. European Pharmacopeia
Drug form
Reglisam
25 mg/1.3 g orally pellets: pack 10 or 30 pcs
reg.
Release form, packaging and composition of Reglisam
Pellets for preparation of an oral solution for children from white to white with a yellowish tint.
1 pack.
ammonium glycyrrhizinate 25 mg
Auxiliary substances: sodium citrate double-substituted (sodium hydrocitrate) - 0.05 g, potato starch - 0.01 g, milk sugar (lactose monohydrate) - 1.215 g.
1.3 g - packages made of plastic-coated packaging paper or laminated paper (10) - packs of cardboard.
1.3 g - packages made of plastic-coated packaging paper or laminated paper (30) - packs of cardboard.
Clinical-pharmacological group: Phytopharmaceutical preparation with expectorant and anti-inflammatory action
Pharmacotherapeutic group Reglisam:
Anti-inflammatory agent
- ICD-10 Code Indication
- E27.1 Primary adrenal insufficiency
- E27.3 Drug-induced adrenal insufficiency
- F48.0 Neurasthenia
- I95 Hypotension
- J20 Acute bronchitis
- J42 Chronic bronchitis, unspecified
- J45 Asthma
- K59.0 Constipation
- L20.8 Other atopic dermatitis (neurodermatitis, eczema)
- L23 Allergic contact dermatitis
- L24 Simple irritable [irritant] contact dermatitis
- L28.0 Lichen simplex chronicus (limited neurodermitis)
- L30.0 Eczema monetoid
Pharmacological effect Reglisam
The preparation regrisam has a pharmacological effect, which is characterized by anti-inflammatory properties, the ability to stimulate the function of the adrenal cortex and perform a moderate expectorant effect.
Testimony Reglisam
Active ingredients of the drug regrisam are recommended for use in certain diseases and conditions. In particular, it can be used as an expectorant in respiratory tract diseases with difficult sputum, including bronchial asthma. Reglisam can also be used for eczema, allergic dermatitis, asthenic conditions, hypotension, Addison disease (in diencephalo-pituitary forms), as monotherapy or in combination with acth. It can also be used to treat adrenal insufficiency after long-term treatment with corticosteroids and to prevent withdrawal while treatment is being stopped or to reduce the dose.
How to take, course of reception and dosage Reglisam
Recommendations as to how a particular drug is to be used and dosed are determined by its form and other factors. The optimal dose should be given by a doctor. It is important to maintain consistency between the formulation, indication, and dosage recommendation. Inside. The dose calculation is carried out individually depending on the patient's age, indications and the form of the drug used.
